Mastermind Session: How Can We Achieve Potency & Durability of Response for More Successful Clinical Outcomes?

Time: 10:30 am
day: Advancing Durability & Persistence Focus Day


  • Discussing why, when compared to the autologous approach, allogeneic therapies are experiencing major issues with durability
  • Investigating reactivation of endogenous immunity from the patient donor’s immunity following allogeneic T-cell infusion
  • Exploring the balance between long-lasting persistence versus the efficacy of the transient allogeneic product
  • Discussing innovations in design and administration to develop a long acting allogeneic cell therapy